Fortrea Holdings Inc. (FTRE) Next Earnings Date & Expected ±12.5% Move

$21.29 -7.97% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $20.94

Fortrea Holdings Inc. (FTRE) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $2.05B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on FTRE Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is FTRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Fortrea Holdings Inc. (NASDAQ: FTRE) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $21.29 (-7.97% 1D, market cap $2.05B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, FTRE ranks #712 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does FTRE compare to CLOV and PSNL in the Health Care sector?
▼

Within the Health Care sector (Medical Specialities), FTRE carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, CLOV (Clover Health Investments Corp. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -29.3%, cap $2.37B) and PSNL (Personalis Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $1.69B). Among the 5-stock peer group, FTRE leads on earnings multiple (N/A) while ALHC leads on capital efficiency (13.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for FTRE?
▼

Per FTRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001965040), Fortrea Holdings Inc. generated $2.72B in revenue (+1.0% YoY), -$989.0M in net income, and -$9.1M in free cash flow against $2.72B in total assets and $1.05B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $20.95 (-1.62%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510032
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk E
Cash (4)Whales (14)SEC (5)Macro (6)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-11.7% Base Target
$27 Bull$19 Base$15 Bear
📬 FREE FTRE RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for FTRE)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY FTRE SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (44% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+6/20 pts (19% of score)

FRED Regime × Technicals: 72% of 52W Range • RSI-14 at 46.4 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
40
Grade D$21.34+12.7% Next Q
Q2 (-2Q)
37
Grade E$24.06+7.6% Next Q
Q3 (-1Q)
35
Grade E$25.88-17.7% Next Q
Current
32
Grade E$21.29-9.2% Hist 90D α
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a FTRE Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While FTRE currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($20.53) and Max Pain ($22.35) forces dealer call-delta covering toward $27.47.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $FTRE• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “FTRE Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
NEXT EST. WINDOW: Dec 30, 2026 (~57 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$2.66 Expected Swing
$18.63 (-12.5%)Spot $21.29$23.95 (+12.5%)
MODEL EARNINGS SETUP GAUGE

FTRE Quantitative Pre-Earnings Setup: 32/100

Trailing EPS: $-10.40 • YoY Revenue Growth: 1%

Model Bullish Setup (32/100)Model Risk Weight (68/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$2.72B-$989.0M-$9.1M52%
FY 20242024-12-31$2.70B-$329.0M$141.5M52%
FY 20232023-12-31$2.84B-$25.0M$40.5M52%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring FTRE)

  • ✓Walkthrough of FTRE's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
FTRE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +73.80%▲ ASCENDING CHANNEL
2026-11-03O $23.13H $23.13L $21.29C $21.29VOL 2.87M
RES: $26.53SUP: $17.67SMA50: $20.53SMA200: $15.79
$27.29$22.60$17.90$13.20$8.50RES $26.53SUP $17.67$21.292026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

FTRE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
22.3%/yr Implied 5Y Growth

vs. +1.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on FTRE today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for FTRE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for FTRE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (FTRE)

Health Care Rank #712 of 1016 ⚔️ CLOV vs FTRE Full Matrix →

1. Head-to-Head Health Care Peer Comparison (FTRE vs. CLOV, PSNL, ALHC, ACHC)

Industry: Medical Specialities (41 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Fortrea Holdings Inc. (FTRE) ranks #712 by composite RQD confidence (32/100, grade E) and #250 by equity capitalization ($2.05B). Within this direct 5-issuer industry benchmark cohort, FTRE leads on earnings valuation at N/A trailing P/E, while ALHC leads on capital efficiency and profitability with 13.9% ROIC and — gross margin. ALHC currently holds the highest overall quantitative score in the immediate peer group at 56/100 (D+) compared with FTRE at 32/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
FTRE ACTIVE
Fortrea Holdings Inc.
E 32/100 — — -35.0% -7.97% $2.05B Benchmark Subject
CLOV
Clover Health Investments Corp. (Class A)
D- 36/100 — — -29.3% -2.62% $2.37B /clov-vs-ftre →
PSNL
Personalis Inc.
D- 36/100 — 22.7% -35.0% -0.66% $1.69B /psnl-vs-ftre →
ALHC
Alignment Healthcare Inc.
D+ 56/100 — — 13.9% -9.80% $1.52B /alhc-vs-ftre →
ACHC
Acadia Healthcare Company Inc.
D- 38/100 — — -24.8% +1.70% $2.79B /achc-vs-ftre →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001965040

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Fortrea Holdings Inc. (FTRE) reported GAAP revenue of $2.72B (+1.0% vs. FY2024 revenue of $2.70B , and -4.2% cumulative change since FY2023) , GAAP net income of -$989.0M, operating cash flow of $113.5M, and free cash flow of -$9.1M (-106.4% YoY). On the balance sheet, FTRE closed FY2025 with $2.72B in total assets against $1.05B in total debt (Altman Z-Score: 0.45, Piotroski F-Score: 3/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $2.72B -$989.0M $113.5M -$9.1M $2.72B $1.05B
FY2024 (FY) 2024-12-31 $2.70B -$329.0M $262.8M $141.5M $3.58B $1.05B
FY2023 (FY) 2023-12-31 $2.84B -$25.0M $168.4M $40.5M $3.41B $798.2M

3. FTRE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is FTRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Fortrea Holdings Inc. (NASDAQ: FTRE) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $21.29 (-7.97% 1D, market cap $2.05B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, FTRE ranks #712 in composite RQD confidence.

How does FTRE compare to CLOV and PSNL in the Health Care sector?

Within the Health Care sector (Medical Specialities), FTRE carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, CLOV (Clover Health Investments Corp. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -29.3%, cap $2.37B) and PSNL (Personalis Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $1.69B). Among the 5-stock peer group, FTRE leads on earnings multiple (N/A) while ALHC leads on capital efficiency (13.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for FTRE?

Per FTRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001965040), Fortrea Holdings Inc. generated $2.72B in revenue (+1.0% YoY), -$989.0M in net income, and -$9.1M in free cash flow against $2.72B in total assets and $1.05B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is FTRE trading relative to its 50-day, 200-day, and 52-week technical levels?

FTRE last traded at $21.29 (-7.97% on volume of 2,873,556 shares), positioning the stock +3.70% above its 50-day simple moving average ($20.53) and +34.83% above its 200-day simple moving average ($15.79). Across its 52-week range of $8.55 to $26.16, FTRE sits at the 72.3% percentile with a 14-day RSI of 46.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($18.63 to $23.95).

FTRE Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is FTRE's next earnings date?

Based on SEC filing cadence, Fortrea Holdings Inc. (FTRE)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is FTRE stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for FTRE, spanning a range between $18.63 and $23.95.

ROARABLE RATING BRIEF • RQD 32/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

FTRE — Fortrea Holdings Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:26:22Z

Roarable Rating Brief: What This Means to a Prospective Investor

The Roarable RQD rating is 35 out of 100, a letter grade of D-, with the verdict "Roarable Sell — Vulnerable Balance Sheet & Flow" (per the Roarable RQD rating). The five pillars are:

  • Fundamental cash engine: 4 / 20. Per the Roarable RQD rating, this reflects ROIC of -35% and an FCF yield of -0.41%. For a prospective investor, the core business is not currently generating returns on invested capital or free cash flow that would support the equity valuation.
  • Whale / 13F flow: 17 / 20. Per the Roarable RQD rating, this pillar captures institutional accumulation and options positioning. It is the strongest pillar and suggests institutional interest, though the source data does not itemize the 13F holders themselves.
  • Insider conviction: 3 / 20. Per the Roarable RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow. The low score indicates insider signals are weak or unsupportive.
  • Macro regime fit: 6 / 20. Per the Roarable RQD rating, beta is 0.99 and sector sensitivity is weighted here. A market-level beta near 1.0 means the stock tracks broad market moves without an offsetting defensive profile.
  • Forensic balance sheet: 5 / 20. Per the Roarable RQD rating, the Altman Z-Score is 0.45, the Piotroski F-Score is 3/9, and Debt/Equity is 1.86. These figures point to financial distress risk and weak balance-sheet quality.

Taken together, the rating frames FTRE as a stock where a strong institutional-flow reading sits against weak cash generation, low insider support, and a stressed balance sheet. The upside case rests on flow and any operating turnaround; the valuation tradeoff is that the reported forward P/E of 29 (per the market data) is set against negative trailing earnings, so the multiple depends on expectations the trailing numbers do not yet confirm.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$2723.4M$-872.6M$-989.0MN/A$-9.1M$174.6M$1048.0M
FY 2024$2696.4M$-161.9M$-329.0MN/A$141.5M$118.5M$1049.7M
FY 2023$2842.5M$32.0M$-25.0MN/A$40.5MN/A$798.2M

Per the SEC financials, revenue moved from $2842.5M (FY 2023) to $2723.4M (FY 2025), while operating income deteriorated from $32.0M to $-872.6M. Per the market data, the operating margin is -32%, the net margin is -36.3%, and the gross margin is 0%. Per the Roarable RQD rating, ROIC is -35%, the Altman Z-Score is 0.45 (a distress-range reading), and the Piotroski F-Score is 3/9. Per the SEC financials, debt was $1048.0M against cash of $174.6M at FY 2025, and the Roarable RQD rating reports Debt/Equity of 1.86.

Recent Catalysts & News Wire Analysis

Six headlines were reported in the news wire, all related to FTRE:

  • A Yahoo Finance report on the stock trading up (rated YELLOW, market wire).
  • A Yahoo Finance report questioning whether the stock is still cheap after a 116% run (YELLOW, market wire).
  • A GuruFocus report that Barclays raised its price target to $26 (GREEN, catalyst).
  • A Seeking Alpha report on the 2026 Q3 results and earnings call presentation dated 2026-10-29 (YELLOW, market wire).
  • A TradingView estimates page (YELLOW, market wire).
  • A Yahoo Finance report on a modest fair-value lift as margin views improve (YELLOW, market wire).

The Barclays price-target raise is the only item flagged as a catalyst. Per the butterfly supply-chain graph, no supply-chain links or proprietary signals are reported. Risk watch: the 116% run noted in one headline sits alongside a day change of -10.61% and a price well above the 52-week low of $8.55, so the stock's recent path is volatile.

Open Questions

  • What is the company's revenue composition and customer base, given that the source data reports financials but no business description?
  • Why did operating income fall from $32.0M (FY 2023) to $-872.6M (FY 2025), and what drove the swing?
  • What is the path to positive free cash flow, given FY 2025 FCF of $-9.1M and an FCF yield of -0.41%?
  • Can debt of $1048.0M be serviced against cash of $174.6M, and what are the maturity terms?
  • What analyst consensus and price targets exist beyond the single Barclays target referenced in the news wire?

FTRE Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Fortrea Holdings Inc. (FTRE) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to FTRE Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

FTRE Bull vs. Bear Conversation Board — What's Your Call at $21.29?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON FTRE 🐻 67% BEARISH CONVICTION
1. Pick Your Side on FTRE:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $20.36 (-12.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is FTRE (D- • RQD 35/100) a Buy at $23.14?

Welcome to the FTRE (Fortrea Holdings Inc.) Roar Pit. Current RQD Composite is 35/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Medical Specialities. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

MU MultipleCompression Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $17.82 (-23.0%)
Spot @ $23.14

Pump the brakes on FTRE — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on FTRE, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Fortrea Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH 🎯 Target: $29.16 (+26.0%)
Spot @ $23.14

FTRE cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on FTRE, the market is fixating on short-term headline noise in Medical Specialities and ignoring the balance sheet and cash flow trajectory. At $23.14 (52-wk range $8.55 - $26.16), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%